Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Directly managed European call · HORIZON-HLTH-2027-01-CARE-02
The title is in English, the language of the official source.
A consortium is required.
The general EU rules ask for at least three independent legal entities from three Member States or associated countries. An SME cannot apply on its own.
- ProgrammeHorizon Europe
- Deadlinecloses in 94 days
- Opening29/10/2026
- Next cut-off17/02/2027
- All cut-offs17/02/2027
- Official type of actionResearch and Innovation Action (RIA)
Framework call: Cluster 1 - Health (Single stage - 2027/1) · HORIZON-HLTH-2027-01
Topics: Biobanks, Clinical Pharmacology, Co-morbidity, Health data, Personalised services, Personalised treatment, Pharmacovigilance, Tertiary prevention
See the call on the European Commission portal
Other calls under Horizon Europe
Short proposal
Next-Generation QKD Systems
Neutral-Atom Platform Technologies
Trapped-Ion Platform Technologies
All calls under Horizon Europe
We classify each call by its official type of action and the general EU rules: collaborative research and innovation actions ask, as a rule, for three entities from three countries; many coordination and support actions and prizes accept a single entity; the EIC Accelerator is for a single company. Whatever the programme regulation does not set stays under “it depends”. The official text of each call prevails.
Origen de los datos: portal Funding & Tenders de la Comisión Europea (datos abiertos).